Please assess the completion status of the following clinical trial:

Trial Title: Effect of Ketanserin After LSD Administration

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age between 25 and 65 years old~2. Sufficient understanding of the German language~3. Understanding of procedures and risks associated with the study~4. Willing to adhere to the protocol and signing of the consent form~5. Willing to refrain from the consumption of illicit psychoactive substances during the study~6. Abstaining from xanthine-based liquids and foods from the evenings prior to the study sessions to the end of the study days~7. Willing not to operate heavy machinery within 48 hours after substance administration~8. Willing to use double-barrier birth control throughout study participation~9. Body mass index between 18-29 kg/m2~Exclusion Criteria:~1. Chronic or acute medical condition~2. Current or previous major psychiatric disorder~3. Psychotic disorder or bipolar disorder in first-degree relatives~4. Hypertension (\>140/90 mmHg) or hypotension (SBP\<85 mmHg)~5. Hallucinogenic substance use (not including cannabis) more than 20 times or any time within the previous two months~6. Pregnancy or current breastfeeding~7. Participation in another clinical trial (currently or within the last 30 days)~8. Use of medication that may interfere with the effects of the study medication~9. Tobacco smoking (\>10 cigarettes/day)~10. Consumption of alcoholic beverages (\>20 drinks/week)

- Gender: ALL
- Minimum Age: 25 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- 100 μg LSD + Ketanserin placebo (Type: EXPERIMENTAL): None
- 100 μg LSD + Ketanserin (40mg) (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).